Gsk (GSK) Capital Leases (2016 - 2018)

Gsk (GSK) has 3 years of Capital Leases data on file, last reported at $56.6 million in Q4 2018.

• In Q4 2018, Capital Leases fell 0.83% year-over-year to $56.6 million; the TTM figure through Dec 2018 stood at $56.6 million (down 0.83% YoY), while the FY2018 annual figure was $58.8 million, up 6.08% from the prior year.
• Capital Leases declined to $56.6 million in Q4 2018, from $57.1 million in the prior quarter.
• Across five years, Capital Leases topped out at $57.1 million in Q4 2017 and bottomed at $51.0 million in Q4 2016.
• A 3-year average of $54.9 million and a median of $56.6 million in 2018 frame the typical range for Capital Leases.
• Annual changes were most pronounced in 2017 — Capital Leases grew 12.0% — and 2018, when it declined 0.83%.
• Year by year, Capital Leases stood at $51.0 million in 2016, then advanced by 12.0% to $57.1 million in 2017, then dropped by 0.83% to $56.6 million in 2018.
• The last three Capital Leases figures came in at $56.6 million (Q4 2018), $57.1 million (Q4 2017), and $51.0 million (Q4 2016), per Business Quant data.

Peer Comparison